CAS: 4312-32-7; 6,7,12B,13-Tetrahydro-4H-[1,3]Dioxolo[4',5':7,8]Isoquinolino[3,2-A][1,3]Dioxolo[4,5-G]Isoquinoline

该化合物是一种自然产生的藻类,主要产自各种植物物种,特别是帕帕韦罗塞亚家族的植物,其特点是复杂的四环结构,其中包括一个苯基利索基诺林框架,该化合物展示了一系列生物活动,包括止痛剂和抗炎特性,使其对药理研究感兴趣; 苯罗平质物质通常以黄晶状固体的形式出现,在乙醇和氯仿等有机溶剂中溶解,但水溶性有限; 其立体化学作用值得注意,因为它作为一种种族混合物存在,其中含有对映物,可能具有不同的生物效应; 化合物与各种生物目标,包括感应器和酶的相互作用,有助于其潜在的治疗应用; 然而,有必要开展进一步研究,以充分阐明其行动机制,并探讨其在临床环境中的功效和安全性.

结构式图片

上下游产品

rac-7-methyl-2,3;9,10-bis-methylenedioxy-berbinium; chloriderac-7-methyl-2,3;9,10-bis-methylenedioxy-berbinium; chloride H-[1,3]dioxolo[4,5-g][1,3]dioxolo[4',5':7,8]isoquino[3,2-a]isoquinoline14-bromo-6,7,12b,13-tetrahydro-4H-[1,3]dioxolo[4,5-g][1,3]dioxolo[4',5':7,8]isoquino[3,2-a]isoquinoline coptisine chloride 7,8-methylenedioxy-2-(3,4-methylenedioxyphenethyl)-1,2,3,4-tetrahydroisoquinolin-3-one protopine corydamine coptisine chloride

合成工艺路线路线简述

    📜N-Methyl-13,14-Dehydrostylopinium Chloride置于sodium Tetrahydroborate体系中,用 甲醇,二甲基亚砜 作为反应溶剂,化学反应 25.5H,反应生成 四氢黄连碱
    参考文献:从protopines到berbines:从库特罗平合成1-甲氧基斯蒂氯平及其n-甲基盐
    标题:从protopines到berbines:从库特罗平合成1-甲氧基斯蒂氯平及其n-甲基盐
    摘要:在改善的条件下将原松树素转化为小bin碱已被用于合成1-甲氧基stylopine.coulteropine,从主要生物碱romneya Coulteri,被用作起始普罗托实现两者的立体控制合成顺式和反式ñ-甲基-1-Methoxystylopinium盐.从头算的结果(b3Lyp / 6-31G ∗∗)与实验数据一致,维持了c-1取代基对小bin素的构象平衡和n-甲基化率的影响.
    DOI:10.1016/s0040-4020(02)00467-2

    海关参考信息

    专利信息


    专利号:WO-2025031833-A1
    优先权日:2023-08-04
    标 题:Recombinant strain and use thereof in production of scoulerine
    发明人:CHEN YUN; JIAO XIANG
    权利人:CHRYSEA LTD; CHEN YUN
    摘要:Disclosed are recombinant yeast strains and a use thereof in the production of a benzylisoquinoline alkaloid. The recombinant yeast strains comprise berberine bridge enzyme. De novo synthesis of scoulerine and a benzylisoquinoline alkaloid is achieved through multiple strategies, and the yield thereof is significantly increased. The recombinant yeast strains provided by the present invention can produce scoulerine and other benzylisoquinoline alkaloids at high efficiency, and has important value in applications.

    专利号:US-10793885-B2
    优先权日:2013-08-16
    标 题 :Compositions and methods for making noscapine and synthesis intermediates thereof
    发明人:FACCHINI PETER JAMES; CHEN XUE; DANG THI THU THUY
    权利人:WILLOW BIOSCIENCES INC
    摘要:Methods for the manufacture of the therapeutic chemical compound noscapine and noscapine synthesis intermediates comprising contacting a noscapine pathway precursor selected from a first canadine derivative, a first papaveroxine derivative and narcotine hemiacetal with at least one of the enzymes selected from the group CYP82Y1, CYP82X1, AT1, CYP82X2, OMT, CXE1 and NOS.

    专利号:CN-106085981-A
    优先权日:2016-06-30
    标题 :Methyltransferase gene involved in the synthesis of sanguinarine and chelerythrine in Boluohui and its application

    专利号:CN-106119265-A
    优先权日:2016-06-30
    标题 :Cytochrome P450 enzyme gene involved in the synthesis of sanguinarine and chelerythrine in Boluohui and its application

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: BANDELIN FJ, MALESH W. Alkaloids of Chelidonium majus, L., leaves and stems. I. dl-Tetrahydrocoptisine. J Am Pharm Assoc Am Pharm Assoc. 1956 Oct;45(10):702-4. doi: 10.1002/jps.3030451014. 23(5):307-12. French. 65(2):294-6. doi: 10.1002/jps.2600650230. 41(1):61-4. doi: 10.1055/s-2007-971675. 41(3):298-302. doi: 10.1055/s-2007-971718. 43(1):51-5. doi: 10.1055/s-2007-971472. 44(3):168-70. doi: 10.1055/s-2007-971432. 45(2):120-2. doi: 10.1055/s-2007-971259. 46(3):320-4. doi: 10.1021/np50027a004. 46(4):466-70. doi: 10.1021/np50028a006. 51(4):319-22. doi: 10.1055/s-2007-969501. 23(11):806-11. Chinese. 23(11):801-5. Chinese. 57(2):156-8. doi: 10.1055/s-2006-960054. 17(2):262-5. doi: 10.1248/bpb.17.262. 62(3):227-31. doi: 10.1055/s-2006-957865. 104(2):131-8. doi: 10.1016/s0304-4017(01)00619-7. 13(6):363-7. doi: 10.1002/pca.669. 278(40):38557-65. doi: 10.1074/jbc.M302470200. Epub 2003 May 5. 27(9):923-9. doi: 10.1007/BF02975845.

    合成参考文献


    摘要:Arzneimittel-Forschung. Drug Research., 26(2187), 1976 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知